Immediate Impact
54 standout
Citing Papers
Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds
2025 Standout
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Works of Yulei Wang being referenced
An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer
2021
A phase I study of DNIB0600A, an antibody-drug conjugate (ADC) targeting NaPi2b, in patients (pts) with non-small cell lung cancer (NSCLC) or platinum-resistant ovarian cancer (OC).
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Yulei Wang | 362 | 446 | 275 | 52 | 1.1k | |
| Yan Chen | 338 | 538 | 361 | 53 | 1.2k | |
| Xiaofeng Zhang | 442 | 355 | 339 | 43 | 1.1k | |
| Rongzhen Luo | 447 | 470 | 257 | 54 | 1.1k | |
| Xiang Zhou | 186 | 589 | 349 | 57 | 1.1k | |
| Zhonghua Wang | 485 | 388 | 336 | 79 | 1.2k | |
| Yuqiang Li | 374 | 488 | 239 | 74 | 1.1k | |
| Wen Xia | 465 | 425 | 226 | 85 | 1.2k | |
| Gang Yu | 229 | 546 | 326 | 57 | 1.4k | |
| Yong‐Song Guan | 274 | 298 | 234 | 52 | 1.1k | |
| Wei Ma | 258 | 480 | 275 | 44 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...